View in EDS

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.

Saved in:
Bibliographic Details
Title: Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.
Authors: Werr L; Department of Experimental Pediatric Oncology and Hematology.; Center for Molecular Medicine Cologne and Department of Experimental Pediatric Oncology, Medical Faculty, and.; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany., Boland J; Department of Experimental Pediatric Oncology and Hematology.; Mildred Scheel School of Oncology, Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany., Petersen J; Department of Experimental Pediatric Oncology and Hematology.; Koeln Fortune Program/Faculty of Medicine, University of Cologne, Cologne, Germany., Iglesias F; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Höppner S; Department of Experimental Pediatric Oncology and Hematology.; Center for Molecular Medicine Cologne and Department of Experimental Pediatric Oncology, Medical Faculty, and.; Mildred Scheel School of Oncology, Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany., Bartenhagen C; Department of Experimental Pediatric Oncology and Hematology.; Center for Molecular Medicine Cologne and Department of Experimental Pediatric Oncology, Medical Faculty, and., Rosswog C; Department of Experimental Pediatric Oncology and Hematology.; Center for Molecular Medicine Cologne and Department of Experimental Pediatric Oncology, Medical Faculty, and.; Else Kröner Forschungskolleg Clonal Evolution in Cancer, University Hospital Cologne, Cologne, Germany., Hellmann AM; Department of Experimental Pediatric Oncology and Hematology.; Center for Molecular Medicine Cologne and Department of Experimental Pediatric Oncology, Medical Faculty, and.; Else Kröner Forschungskolleg Clonal Evolution in Cancer, University Hospital Cologne, Cologne, Germany., Kahlert Y; Department of Experimental Pediatric Oncology and Hematology., Hemstedt N; Department of Experimental Pediatric Oncology and Hematology., Ibruli N; Department of Experimental Pediatric Oncology and Hematology., Dammert MA; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany.; Institute of Pathology, Faculty of Medicine and University Hospital Cologne., Decarolis B; Department of Pediatric Oncology and Hematology, and., Werner JM; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Division of Oncology and Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Malchers F; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany.; Institute of Biochemistry I, Medical Faculty, University of Cologne, Cologne, Germany., Schramm K; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany.; Division of Pediatric Glioma Research (B360) and., Witt O; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany., Beiske KH; Department of Pathology, Oslo University Hospital, Oslo, Norway., Rognlien AGW; Division of Pediatric and Adolescent Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway., Gunnes MW; Division of Pediatric and Adolescent Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway., Langenberg KP; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, Netherlands., Molenaar J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, Netherlands.; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, Netherlands., Bernkopf M; St. Anna Children's Cancer Research Institute, Vienna, Austria., Taschner-Mandl S; St. Anna Children's Cancer Research Institute, Vienna, Austria., Hughes D; Division of Clinical Studies, The Institute of Cancer Research, Sutton, London, United Kingdom., George SL; Division of Clinical Studies, The Institute of Cancer Research, Sutton, London, United Kingdom.; The Francis Crick Institute, London, United Kingdom.; Children and Young People's Unit, The Royal Marsden Hospital, Sutton, London, United Kingdom., Chesler L; Division of Clinical Studies, The Institute of Cancer Research, Sutton, London, United Kingdom., Schulte JH; University Children's Hospital, Eberhard Karls University, Abteilung I, Tuebingen, Germany., Barone G; Great Ormond Street Hospital, London, United Kingdom., Capasso M; Department of Molecular Medicine and Medical Biotechnology, University of Naples 'Federico II,' Naples, Italy.; CEINGE Biotecnologie Avanzate, Napoli, Italy., Surrey LF; Division of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pathology and Laboratory Medicine, and., Bagatell R; Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Masliah-Planchon J; Oncogenetic lab, Institute Curie, Paris, France., Schleiermacher G; Recherche Translationelle en Oncologie Pédiatrique; INSERM U830, and SIREDO Integrated Pediatric Oncology Center, PSL Research University, Institut Curie, Paris, France., Grüll H; Faculty of Medicine and University Hospital of Cologne, Institute of Diagnostic and Interventional Radiology, University of Cologne, Cologne, Germany., Westermann F; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany.; Division of Neuroblastoma Genomics, DFKZ, Heidelberg, Germany., Schultheis AM; Institute of Pathology, Faculty of Medicine and University Hospital Cologne., Büttner R; Institute of Pathology, Faculty of Medicine and University Hospital Cologne., Henssen AG; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; DKTK, Partner Site Berlin, and DKFZ, Heidelberg, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Technology Platform Electron Microscopy, Berlin, Germany.; Experimental and Clinical Research Center of the MDC and Charité Berlin, Berlin, Germany., Eggert A; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Peifer M; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany.; Else Kröner Forschungskolleg Clonal Evolution in Cancer, University Hospital Cologne, Cologne, Germany., Shukla NN; Koeln Fortune Program/Faculty of Medicine, University of Cologne, Cologne, Germany., Simon T; Department of Pediatric Oncology and Hematology, and., Hero B; Department of Pediatric Oncology and Hematology, and., Reinhardt HC; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, DKTK, partner site Essen, Essen, Germany., Thomas RK; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany.; Institute of Pathology, Faculty of Medicine and University Hospital Cologne., Fischer M; Department of Experimental Pediatric Oncology and Hematology.; Center for Molecular Medicine Cologne and Department of Experimental Pediatric Oncology, Medical Faculty, and.
Source: The Journal of clinical investigation [J Clin Invest] 2026 Feb 12; Vol. 136 (7). Date of Electronic Publication: 2026 Feb 12 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41678281
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Werr+L%22">Werr L</searchLink>; Department of Experimental Pediatric Oncology and Hematology.; Center for Molecular Medicine Cologne and Department of Experimental Pediatric Oncology, Medical Faculty, and.; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Boland+J%22">Boland J</searchLink>; Department of Experimental Pediatric Oncology and Hematology.; Mildred Scheel School of Oncology, Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Petersen+J%22">Petersen J</searchLink>; Department of Experimental Pediatric Oncology and Hematology.; Koeln Fortune Program/Faculty of Medicine, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Iglesias+F%22">Iglesias F</searchLink>; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Höppner+S%22">Höppner S</searchLink>; Department of Experimental Pediatric Oncology and Hematology.; Center for Molecular Medicine Cologne and Department of Experimental Pediatric Oncology, Medical Faculty, and.; Mildred Scheel School of Oncology, Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Bartenhagen+C%22">Bartenhagen C</searchLink>; Department of Experimental Pediatric Oncology and Hematology.; Center for Molecular Medicine Cologne and Department of Experimental Pediatric Oncology, Medical Faculty, and.<br /><searchLink fieldCode="AU" term="%22Rosswog+C%22">Rosswog C</searchLink>; Department of Experimental Pediatric Oncology and Hematology.; Center for Molecular Medicine Cologne and Department of Experimental Pediatric Oncology, Medical Faculty, and.; Else Kröner Forschungskolleg Clonal Evolution in Cancer, University Hospital Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Hellmann+AM%22">Hellmann AM</searchLink>; Department of Experimental Pediatric Oncology and Hematology.; Center for Molecular Medicine Cologne and Department of Experimental Pediatric Oncology, Medical Faculty, and.; Else Kröner Forschungskolleg Clonal Evolution in Cancer, University Hospital Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Kahlert+Y%22">Kahlert Y</searchLink>; Department of Experimental Pediatric Oncology and Hematology.<br /><searchLink fieldCode="AU" term="%22Hemstedt+N%22">Hemstedt N</searchLink>; Department of Experimental Pediatric Oncology and Hematology.<br /><searchLink fieldCode="AU" term="%22Ibruli+N%22">Ibruli N</searchLink>; Department of Experimental Pediatric Oncology and Hematology.<br /><searchLink fieldCode="AU" term="%22Dammert+MA%22">Dammert MA</searchLink>; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany.; Institute of Pathology, Faculty of Medicine and University Hospital Cologne.<br /><searchLink fieldCode="AU" term="%22Decarolis+B%22">Decarolis B</searchLink>; Department of Pediatric Oncology and Hematology, and.<br /><searchLink fieldCode="AU" term="%22Werner+JM%22">Werner JM</searchLink>; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Division of Oncology and Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Malchers+F%22">Malchers F</searchLink>; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany.; Institute of Biochemistry I, Medical Faculty, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Schramm+K%22">Schramm K</searchLink>; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany.; Division of Pediatric Glioma Research (B360) and.<br /><searchLink fieldCode="AU" term="%22Witt+O%22">Witt O</searchLink>; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Beiske+KH%22">Beiske KH</searchLink>; Department of Pathology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Rognlien+AGW%22">Rognlien AGW</searchLink>; Division of Pediatric and Adolescent Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Gunnes+MW%22">Gunnes MW</searchLink>; Division of Pediatric and Adolescent Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Langenberg+KP%22">Langenberg KP</searchLink>; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Molenaar+J%22">Molenaar J</searchLink>; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, Netherlands.; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Bernkopf+M%22">Bernkopf M</searchLink>; St. Anna Children's Cancer Research Institute, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Taschner-Mandl+S%22">Taschner-Mandl S</searchLink>; St. Anna Children's Cancer Research Institute, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Hughes+D%22">Hughes D</searchLink>; Division of Clinical Studies, The Institute of Cancer Research, Sutton, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22George+SL%22">George SL</searchLink>; Division of Clinical Studies, The Institute of Cancer Research, Sutton, London, United Kingdom.; The Francis Crick Institute, London, United Kingdom.; Children and Young People's Unit, The Royal Marsden Hospital, Sutton, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Chesler+L%22">Chesler L</searchLink>; Division of Clinical Studies, The Institute of Cancer Research, Sutton, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Schulte+JH%22">Schulte JH</searchLink>; University Children's Hospital, Eberhard Karls University, Abteilung I, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Barone+G%22">Barone G</searchLink>; Great Ormond Street Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Capasso+M%22">Capasso M</searchLink>; Department of Molecular Medicine and Medical Biotechnology, University of Naples 'Federico II,' Naples, Italy.; CEINGE Biotecnologie Avanzate, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Surrey+LF%22">Surrey LF</searchLink>; Division of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pathology and Laboratory Medicine, and.<br /><searchLink fieldCode="AU" term="%22Bagatell+R%22">Bagatell R</searchLink>; Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Masliah-Planchon+J%22">Masliah-Planchon J</searchLink>; Oncogenetic lab, Institute Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Schleiermacher+G%22">Schleiermacher G</searchLink>; Recherche Translationelle en Oncologie Pédiatrique; INSERM U830, and SIREDO Integrated Pediatric Oncology Center, PSL Research University, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Grüll+H%22">Grüll H</searchLink>; Faculty of Medicine and University Hospital of Cologne, Institute of Diagnostic and Interventional Radiology, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Westermann+F%22">Westermann F</searchLink>; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany.; Division of Neuroblastoma Genomics, DFKZ, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schultheis+AM%22">Schultheis AM</searchLink>; Institute of Pathology, Faculty of Medicine and University Hospital Cologne.<br /><searchLink fieldCode="AU" term="%22Büttner+R%22">Büttner R</searchLink>; Institute of Pathology, Faculty of Medicine and University Hospital Cologne.<br /><searchLink fieldCode="AU" term="%22Henssen+AG%22">Henssen AG</searchLink>; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; DKTK, Partner Site Berlin, and DKFZ, Heidelberg, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Technology Platform Electron Microscopy, Berlin, Germany.; Experimental and Clinical Research Center of the MDC and Charité Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Eggert+A%22">Eggert A</searchLink>; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Peifer+M%22">Peifer M</searchLink>; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany.; Else Kröner Forschungskolleg Clonal Evolution in Cancer, University Hospital Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Shukla+NN%22">Shukla NN</searchLink>; Koeln Fortune Program/Faculty of Medicine, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Simon+T%22">Simon T</searchLink>; Department of Pediatric Oncology and Hematology, and.<br /><searchLink fieldCode="AU" term="%22Hero+B%22">Hero B</searchLink>; Department of Pediatric Oncology and Hematology, and.<br /><searchLink fieldCode="AU" term="%22Reinhardt+HC%22">Reinhardt HC</searchLink>; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, DKTK, partner site Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Thomas+RK%22">Thomas RK</searchLink>; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany.; Institute of Pathology, Faculty of Medicine and University Hospital Cologne.<br /><searchLink fieldCode="AU" term="%22Fischer+M%22">Fischer M</searchLink>; Department of Experimental Pediatric Oncology and Hematology.; Center for Molecular Medicine Cologne and Department of Experimental Pediatric Oncology, Medical Faculty, and.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2026 Feb 12; Vol. 136 (7). <i>Date of Electronic Publication: </i>2026 Feb 12 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41678281
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/JCI189152
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Werr L
      – PersonEntity:
          Name:
            NameFull: Boland J
      – PersonEntity:
          Name:
            NameFull: Petersen J
      – PersonEntity:
          Name:
            NameFull: Iglesias F
      – PersonEntity:
          Name:
            NameFull: Höppner S
      – PersonEntity:
          Name:
            NameFull: Bartenhagen C
      – PersonEntity:
          Name:
            NameFull: Rosswog C
      – PersonEntity:
          Name:
            NameFull: Hellmann AM
      – PersonEntity:
          Name:
            NameFull: Kahlert Y
      – PersonEntity:
          Name:
            NameFull: Hemstedt N
      – PersonEntity:
          Name:
            NameFull: Ibruli N
      – PersonEntity:
          Name:
            NameFull: Dammert MA
      – PersonEntity:
          Name:
            NameFull: Decarolis B
      – PersonEntity:
          Name:
            NameFull: Werner JM
      – PersonEntity:
          Name:
            NameFull: Malchers F
      – PersonEntity:
          Name:
            NameFull: Schramm K
      – PersonEntity:
          Name:
            NameFull: Witt O
      – PersonEntity:
          Name:
            NameFull: Beiske KH
      – PersonEntity:
          Name:
            NameFull: Rognlien AGW
      – PersonEntity:
          Name:
            NameFull: Gunnes MW
      – PersonEntity:
          Name:
            NameFull: Langenberg KP
      – PersonEntity:
          Name:
            NameFull: Molenaar J
      – PersonEntity:
          Name:
            NameFull: Bernkopf M
      – PersonEntity:
          Name:
            NameFull: Taschner-Mandl S
      – PersonEntity:
          Name:
            NameFull: Hughes D
      – PersonEntity:
          Name:
            NameFull: George SL
      – PersonEntity:
          Name:
            NameFull: Chesler L
      – PersonEntity:
          Name:
            NameFull: Schulte JH
      – PersonEntity:
          Name:
            NameFull: Barone G
      – PersonEntity:
          Name:
            NameFull: Capasso M
      – PersonEntity:
          Name:
            NameFull: Surrey LF
      – PersonEntity:
          Name:
            NameFull: Bagatell R
      – PersonEntity:
          Name:
            NameFull: Masliah-Planchon J
      – PersonEntity:
          Name:
            NameFull: Schleiermacher G
      – PersonEntity:
          Name:
            NameFull: Grüll H
      – PersonEntity:
          Name:
            NameFull: Westermann F
      – PersonEntity:
          Name:
            NameFull: Schultheis AM
      – PersonEntity:
          Name:
            NameFull: Büttner R
      – PersonEntity:
          Name:
            NameFull: Henssen AG
      – PersonEntity:
          Name:
            NameFull: Eggert A
      – PersonEntity:
          Name:
            NameFull: Peifer M
      – PersonEntity:
          Name:
            NameFull: Shukla NN
      – PersonEntity:
          Name:
            NameFull: Simon T
      – PersonEntity:
          Name:
            NameFull: Hero B
      – PersonEntity:
          Name:
            NameFull: Reinhardt HC
      – PersonEntity:
          Name:
            NameFull: Thomas RK
      – PersonEntity:
          Name:
            NameFull: Fischer M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 02
              Text: 2026 Feb 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1558-8238
          Numbering:
            – Type: volume
              Value: 136
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: The Journal of clinical investigation
              Type: main
ResultId 1